![Dong-Young Son](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dong-Young Son
Corporate Officer/Principal en Pai Chai University .
Perfil
Dong-Young Son is a Professor at Pai Chai University since 2013.
He previously worked as an Independent Director at KB No.
3 Special Purpose Acquisition Co. and Sphere Power, Inc. Mr. Son completed his undergraduate degree at Seoul National University and his graduate degree at Konkuk University.
Cargos activos de Dong-Young Son
Empresas | Cargo | Inicio |
---|---|---|
Pai Chai University | Corporate Officer/Principal | 01/03/2013 |
Antiguos cargos conocidos de Dong-Young Son.
Empresas | Cargo | Fin |
---|---|---|
SPHERE POWER INC. | Director/Miembro de la Junta | - |
KB No. 3 Special Purpose Acquistion Co.
![]() KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Director/Miembro de la Junta | - |
Formación de Dong-Young Son.
Seoul National University | Undergraduate Degree |
Konkuk University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SPHERE POWER INC. | Health Technology |
Empresas privadas | 1 |
---|---|
KB No. 3 Special Purpose Acquistion Co.
![]() KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Finance |
- Bolsa de valores
- Insiders
- Dong-Young Son